Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -23.34%448.7M | ---- | 13.73%585.3M | ---- | -67.46%514.65M | ---- | 11.73%1.58B | ---- | 85.16%1.42B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 20.93%-27.82M | ---- | -7.53%-35.19M | ---- | 15.18%-32.73M | ---- | 0.54%-38.58M | ---- | -128.20%-38.79M |
| Attributable subsidiary (profit) loss | ---- | 72.31%-8.46M | ---- | 2.25%-30.53M | ---- | 36.35%-31.24M | ---- | 2.02%-49.08M | ---- | -11.47%-50.09M |
| Impairment and provisions: | ---- | 414.23%12.01M | ---- | -73.10%-3.82M | ---- | -87.44%-2.21M | ---- | -100.37%-1.18M | ---- | 3,488.62%316.63M |
| -Impairment of trade receivables (reversal) | ---- | 234.36%6.43M | ---- | ---4.79M | ---- | ---- | ---- | ---- | ---- | 3,555.21%25.53M |
| -Other impairments and provisions | ---- | 477.33%5.58M | ---- | 143.75%966K | ---- | -87.44%-2.21M | ---- | -100.40%-1.18M | ---- | 3,482.91%291.1M |
| Revaluation surplus: | ---- | -2.53%423K | ---- | -22.64%434K | ---- | 0.72%561K | ---- | 15.80%557K | ---- | -69.54%481K |
| -Fair value of investment properties (increase) | ---- | -2.53%423K | ---- | -22.64%434K | ---- | 0.72%561K | ---- | 15.80%557K | ---- | -69.54%481K |
| Asset sale loss (gain): | ---- | -82.83%2.36M | ---- | 1,013.63%13.73M | ---- | -60.82%1.23M | ---- | -50.94%3.15M | ---- | 133.90%6.42M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -82.83%2.36M | ---- | 1,013.63%13.73M | ---- | -72.79%1.23M | ---- | -29.35%4.53M | ---- | 133.90%6.42M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.39M | ---- | ---- |
| Depreciation and amortization: | ---- | 2.58%618.6M | ---- | 6.19%603.06M | ---- | 6.44%567.91M | ---- | 14.26%533.57M | ---- | 13.19%466.99M |
| -Amortization of intangible assets | ---- | -1.36%83.7M | ---- | 11.64%84.86M | ---- | -0.55%76.01M | ---- | -7.80%76.42M | ---- | 18.89%82.89M |
| Financial expense | ---- | -4.05%629.49M | ---- | 99.18%656.07M | ---- | 73.70%329.38M | ---- | -25.88%189.63M | ---- | -25.68%255.85M |
| Exchange Loss (gain) | ---- | -32.09%39.4M | ---- | -89.07%58.02M | ---- | 642.97%530.98M | ---- | 77.36%-97.79M | ---- | -270.87%-431.89M |
| Operating profit before the change of operating capital | ---- | -7.17%1.71B | ---- | -1.68%1.85B | ---- | -11.46%1.88B | ---- | 9.31%2.12B | ---- | 12.25%1.94B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -4.91%57.7M | ---- | 287.63%60.68M | ---- | 60.23%-32.34M | ---- | 2.37%-81.31M | ---- | 37.63%-83.28M |
| Developing property (increase)decrease | ---- | 42.03%-35.39M | ---- | -132.10%-61.05M | ---- | 51.26%-26.3M | ---- | -17.65%-53.96M | ---- | -69.56%-45.87M |
| Accounts receivable (increase)decrease | ---- | 220.10%355.86M | ---- | -1,584.87%-296.29M | ---- | 109.10%19.95M | ---- | 40.76%-219.28M | ---- | -214.06%-370.15M |
| Accounts payable increase (decrease) | ---- | -160.52%-56.24M | ---- | 235.50%92.93M | ---- | 73.29%-68.58M | ---- | -129.69%-256.74M | ---- | 630.04%864.63M |
| prepayments (increase)decrease | ---- | -434.13%-154M | ---- | 415.68%46.09M | ---- | 14.41%-14.6M | ---- | 95.89%-17.06M | ---- | 16.46%-415.09M |
| Special items for working capital changes | ---- | -695.36%-510.63M | ---- | 239.06%85.77M | ---- | -111.65%-61.68M | ---- | 151.19%529.57M | ---- | 319.17%210.82M |
| Cash from business operations | ---- | -22.71%1.37B | ---- | 4.73%1.78B | ---- | -16.21%1.69B | ---- | -3.76%2.02B | ---- | 84.89%2.1B |
| Other taxs | ---- | -14.30%-323.84M | ---- | 8.30%-283.32M | ---- | -27.30%-308.98M | ---- | -5.26%-242.72M | ---- | -20.58%-230.58M |
| Interest received - operating | ---- | -62.06%4.5M | ---- | 26.19%11.87M | ---- | -38.38%9.41M | ---- | 4.71%15.26M | ---- | -14.24%14.58M |
| Special items of business | -179.78%-252.9M | ---- | -48.54%317M | ---- | -34.62%615.98M | ---- | 128.77%942.08M | ---- | -33.34%411.81M | ---- |
| Net cash from operations | -179.78%-252.9M | -30.00%1.05B | -48.54%317M | 7.76%1.5B | -34.62%615.98M | -22.28%1.4B | 128.77%942.08M | -4.80%1.8B | -33.34%411.81M | 95.91%1.89B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --33.74M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --60.24M | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | 212.80%48.92M | ---- | -864.27%-43.37M | ---- | -179.20%-4.5M |
| Sale of fixed assets | ---- | 11.30%31.02M | ---- | -58.15%27.87M | ---- | 22.36%66.58M | ---- | 141.44%54.41M | ---- | -27.39%22.54M |
| Purchase of fixed assets | ---- | 23.96%-702.25M | ---- | 23.50%-923.53M | ---- | 20.20%-1.21B | ---- | 19.23%-1.51B | ---- | -18.57%-1.87B |
| Purchase of intangible assets | ---- | -195.92%-17.05M | ---- | 90.55%-5.76M | ---- | -160.04%-60.94M | ---- | -3,214.43%-23.43M | ---- | 99.18%-707K |
| Acquisition of subsidiaries | ---- | 61.98%-23.96M | ---- | 19.96%-63.02M | ---- | -229.82%-78.74M | ---- | -88.04%-23.87M | ---- | 98.34%-12.7M |
| Cash on investment | ---- | ---50.4M | ---- | ---- | ---- | 49.40%-86.99M | ---- | -1,576.89%-171.93M | ---- | 81.96%-10.25M |
| Other items in the investment business | 15.64%-500.99M | ---15.9M | -16.00%-593.84M | ---- | 32.16%-511.94M | ---- | 14.46%-754.67M | ---- | 23.39%-882.22M | ---- |
| Net cash from investment operations | 15.64%-500.99M | 19.28%-778.54M | -16.00%-593.84M | 26.85%-964.44M | 32.16%-511.94M | 18.97%-1.32B | 14.46%-754.67M | 13.40%-1.63B | 23.39%-882.22M | 23.35%-1.88B |
| Net cash before financing | -172.32%-753.88M | -49.17%274.11M | -366.07%-276.83M | 600.42%539.3M | -44.48%104.04M | -54.30%77M | 139.84%187.41M | 2,181.15%168.49M | 11.87%-470.41M | 100.50%7.39M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 25.82%9.11B | ---- | 59.39%7.24B | ---- | -40.93%4.54B | ---- | 21.45%7.69B | ---- | -14.05%6.33B |
| Refund | ---- | -28.05%-8.26B | ---- | -56.71%-6.45B | ---- | 49.35%-4.12B | ---- | -36.99%-8.13B | ---- | -26.11%-5.93B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.1B | ---- | ---- |
| Interest paid - financing | ---- | -4.24%-725.7M | ---- | -83.90%-696.17M | ---- | -21.43%-378.56M | ---- | 11.50%-311.75M | ---- | 6.23%-352.27M |
| Dividends paid - financing | ---- | 61.27%-27.98M | ---- | 84.50%-72.25M | ---- | -76.35%-466.17M | ---- | -30.98%-264.33M | ---- | 27.91%-201.82M |
| Absorb investment income | ---- | -83.96%2.14M | ---- | -8.38%13.33M | ---- | -42.63%14.55M | ---- | -48.27%25.37M | ---- | 70.25%49.03M |
| Issuance expenses and redemption of securities expenses | ---- | 60.04%-79.42M | ---- | -774.05%-198.75M | ---- | -136.35%-22.74M | ---- | ---9.62M | ---- | ---- |
| Other items of the financing business | -38.77%-236.52M | 64.97%-28.55M | -131.13%-170.44M | -8,216.94%-81.51M | 479.11%547.45M | 99.25%-980K | -66.24%-144.4M | -74.97%-130.23M | -236.35%-86.87M | -288.83%-74.43M |
| Net cash from financing operations | -38.77%-236.52M | 94.89%-12.71M | -131.13%-170.44M | 42.68%-248.79M | 479.11%547.45M | -903.25%-434.01M | -66.24%-144.4M | 82.86%-43.26M | -236.35%-86.87M | -113.41%-252.46M |
| Effect of rate | 85.07%-3.53M | -27.12%-133.23M | 69.45%-23.62M | 17.40%-104.81M | -22.93%-77.3M | -160.74%-126.88M | -500.36%-62.88M | -156.55%-48.66M | 157.01%15.71M | 199.58%86.06M |
| Net Cash | -121.43%-990.4M | -10.02%261.4M | -168.65%-447.27M | 181.37%290.51M | 1,414.89%651.49M | -385.09%-357.01M | 107.72%43.01M | 151.10%125.23M | -18.55%-557.28M | -162.11%-245.07M |
| Begining period cash | 8.42%1.65B | 13.89%1.52B | 13.89%1.52B | -26.57%1.34B | -26.57%1.34B | 4.39%1.82B | 4.39%1.82B | -8.35%1.74B | -8.35%1.74B | 19.32%1.9B |
| Cash at the end | -37.54%656.93M | 8.42%1.65B | -44.97%1.05B | 13.89%1.52B | 6.12%1.91B | -26.57%1.34B | 49.74%1.8B | 4.39%1.82B | -14.44%1.2B | -8.35%1.74B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.